DHAI with bullish thesis

🔥  Global robotics and virtual reality technology services company, serving healthcare industry clients and patients
🔥 Positioned as leader in the rapidly growing rehabilitation tech industry with an estimated total global market of $15bn
🔥 Collaboration with world renowned institutions, including Mayo Clinic, John's Hopkins and Cleveland Clinic
🔥 Nearly 1500 published research studies, many of which are groundbreaking, almost 50 ongoing studies, and many international innovation awards
🔥 Excellent financials with 60% YoY revenue growth and 25% YoY gross profit growth, and nearly 20% increase in sales orders (all from 1H23 to 1H24)
🔥 Undervalued with a total market cap less than $50m, especially considering profitable subsidiaries Motek and Hocoma
🔥 Excellent technical setup with a 4-hour breakout pattern, trading deceptively thin, now poised for penetration of the $3 threshold level towards $5+
Summary: as a profitable global leader and innovator in a rapidly growing rehab tech industry with reputable clientele and groundbreaking products, DIH is a strong buy 👍